[A correction of lipid peroxidation and antioxidant defense by enterosorption with the use of polysorbates during the combined treatment of the III/IV stage ovarian cancer].
In 62 patients with ovarial cancer of III-IV stage under the influence of enterosorption using polysorb the contents of primary and intermediate products of peroxidal oxidation of lipids have reduced and the antioxidant system indexes did not change.
Temchenko
O I
OI
Klishch
I M
IM
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000378:metabolism*; D003131:Combined Modality Therapy; D016061:Enterosorption / Q000379:methods*; D005260:Female; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000628:therapy*; D011136:Polysorbates / Q000494:pharmacology* / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000494:pharmacology* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D000975:Antioxidants; D011136:Polysorbates; D013501:Surface-Active Agents